| scholarly article | Q13442814 |
| P356 | DOI | 10.1158/1078-0432.CCR-05-0541 |
| P8608 | Fatcat ID | release_xbwiagszcbgyxldccrhiqjxxcm |
| P698 | PubMed publication ID | 16166420 |
| P50 | author | Fulvio Basolo | Q56642492 |
| Marco Lucchi | Q57043106 | ||
| Pinuccia Faviana | Q58051534 | ||
| Alfredo Mussi | Q114739681 | ||
| Valentina Donati | Q114739695 | ||
| Tiziano Camacci | Q114739696 | ||
| Gabriella Fontanini | Q39406171 | ||
| Laura Boldrini | Q42805641 | ||
| Matteo Dell'Omodarme | Q47430366 | ||
| P2093 | author name string | Massimo Santoro | |
| Maria C Prati | |||
| P433 | issue | 18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | non-small-cell lung carcinoma | Q3658562 |
| P304 | page(s) | 6459-6465 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Osteopontin expression and prognostic significance in non-small cell lung cancer | |
| P478 | volume | 11 |
| Q33521107 | A white-box approach to microarray probe response characterization: the BaFL pipeline |
| Q53263258 | Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice. |
| Q84243823 | Comparison of osteopontin, beta-catenin and hnRNP B1 expression in lung carcinomas |
| Q64232823 | Correlation of OPN gene expression with proliferation and apoptosis of ovarian cancer cells and prognosis of patients |
| Q36654589 | Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer |
| Q35953813 | Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. |
| Q38679294 | Epithelial Mesenchymal Transition in Aggressive Lung Cancers |
| Q34361505 | Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer |
| Q36612278 | Expression of osteopontin in oesophageal squamous cell carcinoma |
| Q36473639 | Functional divergence and convergence between the transcript network and gene network in lung adenocarcinoma |
| Q35065341 | Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer. |
| Q36036337 | GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas |
| Q37263338 | Hypoxia, angiogenesis, and lung cancer |
| Q38767694 | Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin |
| Q31145455 | Integrated molecular portrait of non-small cell lung cancers |
| Q36618490 | Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer. |
| Q43501092 | Integrins and their ligands are expressed in non-small cell lung cancer but not correlated with parameters of disease progression |
| Q39789110 | Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity. |
| Q39234093 | Mapping lung tumor cell drug responses as a function of matrix context and genotype using cell microarrays |
| Q36616301 | Multiple molecular targets in cancer chemoprevention by curcumin |
| Q26798763 | OPN -Revisited |
| Q42200175 | OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC |
| Q36610720 | OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. |
| Q89735566 | Osteopontin Mediates Cetuximab Resistance via the MAPK Pathway in NSCLC Cells |
| Q36079101 | Osteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer |
| Q95725200 | Osteopontin b and c Splice isoforms in Leukemias and Solid Tumors: Angiogenesis Alongside Chemoresistance |
| Q35038432 | Osteopontin is a prognostic biomarker in non-small cell lung cancer |
| Q84791536 | Osteopontin predicts survival in critically ill patients with acute kidney injury |
| Q57073431 | Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer |
| Q30316974 | Prognostic information of serial plasma osteopontin measurement in radiotherapy of non-small-cell lung cancer |
| Q35753610 | Prognostic significance of osteopontin expression in non-small-cell lung cancer: A meta-analysis |
| Q35558111 | Prognostic significance of osteopontin in patients with lung cancer: a meta-analysis |
| Q36182815 | Prognostic significance of osteopontin in patients with non-small cell lung cancer: results from a meta-analysis |
| Q33584942 | Prognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancer |
| Q33710746 | Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer |
| Q34992484 | Regulation of Erk1/2 activation by osteopontin in PC3 human prostate cancer cells |
| Q34655823 | Small integrin-binding ligand N-linked glycoproteins (SIBLINGs): multifunctional proteins in cancer |
| Q35863920 | The association between osteopontin and survival in non-small-cell lung cancer patients: a meta-analysis of 13 cohorts |
| Q79756613 | The prognostic significance of preoperative plasma levels of osteopontin in patients with hepatocellular carcinoma |
| Q87851600 | The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis |
| Q34503882 | Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression |
Search more.